文章核心观点 - 尽管UnitedHealth集团第三季度业绩强劲,但受到医疗成本上升和全球商业及Medicaid会员下降的影响,公司不得不下调了业绩预期,未能达到市场预期 [1][4][5] - 这一表现令投资者担心UnitedHealth的困境可能会影响整个行业 [2] - 公司面临的主要挑战包括政府医疗保险项目支付下降、医疗成本上升,以及拜登政府对Medicare Advantage计划的拟议改革 [7] - 为应对这些挑战,公司正采取降低开支、转向更便宜药品替代品、缩短住院时间等措施,但短期内难以根本解决问题 [8][10] - 从估值角度来看,UnitedHealth股价相对同行偏高,且呈现下行趋势,投资者可能需要谨慎观望 [13][14] 公司业绩分析 - 第三季度调整后每股收益7.15美元,超出市场预期1.9% [4] - 收入达到1008亿美元,同比增长9.1%,也超出市场预期 [4] - UnitedHealthcare业务收入增长7.2%,Optum业务收入增长12.7% [4] - 但医疗费用率上升290个基点至85.2%,高于预期 [4] - 总运营成本同比增长近10% [4] - 会员人数同比下降4%至5070万人 [4] 公司前景展望 - 2024年调整后每股收益预期下调至27.50-27.75美元,低于此前预期 [5] - 2025年调整后每股收益预期约30美元,低于市场预期30.37美元 [5] - 公司面临政府医疗保险项目支付下降、医疗成本上升等挑战 [7][10] - 公司正采取降低开支、转向更便宜药品替代品等措施应对 [8] - 但短期内难以根本解决问题,行业整体可能会通过提高商业保险费率来抵消部分负面影响 [9][10] - 此外,公司还需承担Change Healthcare网络攻击事件带来的直接和间接成本 [10][11] 行业动态 - 整个行业面临政府医疗保险项目支付下降、医疗成本上升等共同挑战 [7][12] - 行业内公司正采取各种措施应对,如提高商业保险费率、加强成本控制等 [9][10] - 但短期内难以根本解决问题,行业整体前景仍存在不确定性 [12]

文章核心观点 - 作者是一名全职分析师,对各类股票感兴趣,希望提供独特的见解和知识,为其他投资者提供不同的投资组合视角 [1] - 作者没有持有任何所提及公司的股票、期权或类似衍生工具,也没有在未来72小时内有任何此类计划,文章为其本人观点,未收到任何报酬 [1] 行业和公司研究 风险提示 - 分析仅供参考,不构成专业投资建议,投资前需要进行深入研究和尽职调查,存在资本损失风险 [2] - 过往表现不代表未来结果,任何建议或意见不代表Seeking Alpha的整体观点,Seeking Alpha不是持牌证券交易商、经纪商或投资顾问 [2]

UnitedHealth Group's UNH stock price pulled back following the Q3 earnings release in what can best be described as a temper tantrum. The results weren't bad, outpacing the consensus estimates and compounded by solid guidance, but the market wanted more, so it sold off.  The takeaway is that this healthy, dividend-paying growth machine is executing despite the headwinds and delivering value for investors; the post-release dip is a buying opportunity. Value building is expected to continue in Q4 and next yea ...

文章核心观点 - UnitedHealth Group和Elevance Health是美国两大最大的医疗保险公司 [1] - 两家公司在业务模式和增长方面存在关键差异 [1] 行业概况 - 医疗保险行业是一个重要的行业,两家公司在行业中扮演着重要角色 [1] - 行业研究专家Joseph Jones有15年以上的从业经验,专注于从股息增长投资者的角度进行投资组合构建 [1] 分析师披露 - 分析师拥有Elevance Health的长期有利头寸,包括股票所有权、期权或其他衍生工具 [1] - 分析师撰写本文是出于自己的观点,未获得任何报酬(除了来自Seeking Alpha的报酬) [1] - 分析师与本文提到的任何公司都没有业务关系 [1] Seeking Alpha披露 - 过去的业绩不能保证未来的结果 [2] - Seeking Alpha不是注册的证券交易商、经纪商或美国投资顾问或投资银行 [2] - Seeking Alpha的分析师是第三方作者,包括专业投资者和非专业投资者,可能未经任何机构或监管机构的认证 [2]

HONG KONG, CHINA - 2024/06/23: In this photo illustration, the American multinational managed ... [+] healthcare and insurance company UnitedHealth Group (NYSE: UNH) logo seen displayed on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesUnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations. The comp ...

UnitedHealth Group TodayUNHUnitedHealth Group$571.30 +15.01 (+2.70%) 52-Week Range$436.38▼$608.63Dividend Yield1.47%P/E Ratio37.88Price Target$615.16Add to WatchlistUnitedHealth Group's NYSE: UNH stock price pulled back following the Q3 earnings release in what can best be described as a temper tantrum. The results weren’t bad, outpacing the consensus estimates and compounded by solid guidance, but the market wanted more, so it sold off. The takeaway is that this healthy, dividend-paying growth machine is e ...

文章核心观点 - 公司第三季度业绩超预期,调整后每股收益为7.15美元,超过市场预期 [2] - 公司医疗成本超出预期约80个基点,主要原因包括某些医院系统的Medicare编码强度上升约20% [2][3][5][8] - 公司预计2025年每股收益可能达到高端指引,但仍低于市场预期 [3][5][7] 根据相关目录分别进行总结 行业分析 - 公司医疗损失率(MLR)高于预期,可能在第四季度进一步恶化 [4] - 公司面临一些持续性压力,包括Medicaid重新认定导致的费率/风险调整错配,以及医院编码强度上升 [5][8] - 公司正面临药品成本上升压力,部分原因是患者提前利用了通胀减免法案(IRA)带来的利好 [8] 公司经营 - 公司第三季度业绩整体良好,体现了消费者群体的广泛增长和运营效率的提升 [2] - 公司2025年初步指引保守,主要由于流动性环境不确定性 [6] - 公司计划在2025年实现每股收益高于30美元,但仍低于市场预期 [3][5] - 公司决定维持有机投资,可能推迟加速收益增长的时间至2026年 [7]

If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.UnitedHealth Group (NYSE: UNH ), the world's third-largest healthcare company by market cap valuation (at the time of writing, at least) and the only healthcare company bes ...

I prefer to look for GARP (growth at a reasonable price) stocks but also look for opportunities everywhere else. I don't have a specified time horizon. I invest in a stock for as long as my thesis holds true, and I get out when the facts change. In addition, I've developed market-beating algorithms with Python that have helped me find attractive investment opportunities within my own portfolio, and I have been investing since 2016.On top of that, I've worked at TipRanks as an analysis/news writer and even a ...

UnitedHealth Group Incorporated (UNH) reported third-quarter 2024 adjusted earnings per share (EPS) of $7.15, which surpassed the Zacks Consensus Estimate by 1.9%. The bottom line advanced 9% year over year.Revenues rose 9.1% year over year to $100.8 billion, attributable to a higher number of people served through the UnitedHealthcare and Optum businesses. The top line beat the consensus mark by 1.3%.The quarterly performance was aided by domestic commercial membership growth, value-based care expansion in ...